Tag: united
-
Drug resistance in people and animals may push millions into poverty: World Bank
By Alex Whiting ROME (Thomson Reuters Foundation) – If drug-resistant infections in people and animals are allowed to spread unchecked, some 28 million people will fall into poverty by 2050, and a century of progress in health will be reversed, the World Bank said on Monday. By 2050, annual global GDP would fall by at least…
-
Astellas, Vical herpes vaccine fails mid-stage study
(Reuters) – Japan’s Astellas Pharma Inc and San Diego-based Vical Inc said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients. Vical’s shares was down about 18 percent in light premarket trading on Monday. The DNA vaccine, ASP0113, is designed to prevent cytomegalovirus (CMV) disease in patients receiving a renal transplant…
-
Cycling-Data leak boosts Froome, puts Wiggins in spotlight
By Alan Baldwin LONDON, Sept 19 (Reuters) – Chris Froome’s credibility as triple Tour de France champion has only been boosted by the hacking of his private medical information, according to a South African physiologist who carried out tests on the Briton last year. Jeroen Swart, in an interview with the Cycling Tips website, suggested,…
-
Canadian smart sport bra maker gets $10 million to take on fitness giants
By Alastair Sharp TORONTO (Reuters) – A small Canadian company has raised $10 million to take on Nike Inc , Under Armour Inc and others with a sensor-rich sports bra its chief executive says is more useful than a smart watch and more comfortable than a heart rate monitor. Montreal-based OMsignal hopes the funding round,…
-
GE brings off-the-shelf biotech drug factories to Ireland
General Electric is digging deeper into biotechnology with plans to build four prefabricated drug factories in Ireland, bringing to Europe a low-cost manufacturing concept it first pioneered in China. The new factories on the site will be owned and run by GE customers. The GE BioPark Cork site is expected to create 500 jobs when…
-
Bayer clinches Monsanto with improved $66 billion bid
NEW YORK/FRANKFURT (Reuters) – German drug and crop chemical maker Bayer clinched a $66 billion takeover of U.S. seeds company Monsanto on Wednesday, ending months of wrangling with a third sweetened offer that marks the largest all-cash deal on record. The $128-a-share deal, up from Bayer's previous offer of $127.50 a share, has emerged as…
-
Global ad spend strengthens on U.S. demand: Zenith
Spending on global advertising will grow by a better-than-expected 4.4 percent this year, led by the United States, a leading forecaster said on Monday. Zenith, owned by France's Publicis , raised its global growth forecast for this year from the 4.1 percent it predicted in June, despite the uncertainty sparked by Britain's vote to leave…